Please visit our MS learning channel on Youtube, which provides hundreds of topics from our education programs, that were video-recorded and archived here: www.youtube.com/msviewsandnews

joomla ecommerce template -- Scroll left side of this blog for needed resources. Also, use our 'search by topic' tool, to find specific information.

Disclaimer: 'MS Views and News' DOES NOT endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, and procedures for your personal knowledge and to keep you informed of current health-related issues. It is not intended to be complete or exhaustive, nor is it a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.

=================

CHAMPIONS TACKLING MS - AWARDS Dinner, Honoring Aaron Boster, MD and Jon e. Glaser, DDS - now open for registration. Visit www.events.msvn.org

Wednesday, March 29, 2017

OCREVUS information


                                                                  
  OCREVUS multiple sclerosis logo

NOW APPROVED



 


MS Views and News is MAKING an IMPACT on those affected by Multiple Sclerosis

2 comments:

Ellen Lerner said...

When the information says this drug is for RRMS patients as well as those with advance cases, does this apply to all RRMS Patients or just those patients that don't respond to other forms of treatment? I also hear it's extremely expensive so how are most people supposed to afford this? I'm not convinced insurance companies will cover any of it.

Stuart said...

OCREVUS (TM) - Ocrelizumab - is labeled for All forms of RRMS (RMS) and PPMS.
Learn more from here: https://www.ocrevus.com